Contrast-induced Nephropathy: Who is the High-Risk Patient?
CINDY L. GRINES, MD
Vice Chief of Academic Affairs
Division of Cardiology
William Beaumont Hospital, Royal Oak, MI
Safety of Angiographic Contrast Media in High-Risk Patients: Data from the CARE Study
JONATHAN S. REINER, MD
Professor of Medicine
Director, Cardiac Catheterization Laboratory
George Washington University Medical Center, Washington, DC
Reducing Risk in Patients with Renal Impairment Undergoing Cardiac Angiography
ROXANA MEHRAN, MD
Columbia University Medical Center
Associate Professor of Medicine
Director of Outcomes Research, Data Coordination & Analysis for the Center for Interventional Vascular Therapies
Cardiovascular Research Foundation
Director of Data Coordinating & Analysis Center, New York, NY
This educational initiative has been developed for physicians, nurses, and technologists.
There is no fee for this activity.
LEARNING OBJECTIVES: Upon completion of this educational activity, participants should be able to:
• Discuss optimal risk-factor modification.
• Review prior clinical trial data evaluating contrast-induced nephropathy in high-risk patients.
• Discuss the complication of contrast-induced nephropathy, including how to recognize it and how to avoid
it as well as current trials in preventing contrast-induced nephropathy.
ACCREDITATION
MD/DO: This activity is sponsored by the North American Center for Continuing Medical Education
(NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians. NACCME designates this educational activity for a
maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the
extent of their participation in the activity. This activity has been planned and produced in accordance with
the ACCME Essential Areas and Policies.
TECHNOLOGISTS: Approved for 1 Category A, ARRT continuing education credit by the American Healthcare Radiology Administrators. Reference # END658
NURSES: ANCC: NACCME is an approved provider of continuing nursing education by the Pennsylvania
State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s
Commission on Accreditation. This continuing nursing education activity was approved by the PA State
Nurses Association for 1 contact hour (Provider # 110-3-E-06). Provider approved by the California Board of
Registered Nursing, Provider Number 13255, for 1 contact hour.
FACULTY DISCLOSURES: All those with control over the content of continuing education programs sponsored by
NACCME are expected to disclose whether they do or do not have any real or apparent conflict(s) of interest or
other relationships related to the content of their presentation(s). It is not assumed that these relationships will
have an adverse impact on presentations. Full faculty disclosure will be made at the beginning of the activity.
This activity is supported by an educational grant from Bracco Diagnostics Inc..
Sponsored by the North American Center for Continuing Medical Education (NACCME).